Literature DB >> 718961

Purification of thymidine phosphorylase from human amniochorion.

J Kubilus, L D Lee, H P Baden.   

Abstract

Thymidine phosphorylase (thymidine : orthophosphate deoxyribosyltransferase, EC 2.4.2.4) has been purified 1500-fold from extracts of human amniochorion. The purified enzyme catalyzes the phosphorolysis of deoxythymidine and to a lesser extent deoxyuridine but not deoxycytidine nor uridine. Discontinuous gel electrophoresis of the freshly purified enzyme shows a band containing 95% of the stainable protein. Gradient gel electrophoresis resolves the preparations into an active fraction with an apparent molecular weight of about 120 000 and a heavier less active or inactive fraction of about 180 000. Storage of the enzyme results in a decrease of the 120 000 dalton component, a loss in activity, and an apparent increase in the high molecular weight component. Sodium dodecyl sulfate gel electrophoresis shows only a single subunit of about 58 000 daltons which does not change on storage. These data are consistent with an active enzyme dimeric in structure which is capable of being converted to a less active form larger in molecular weight and possibly trimeric or tetrameric in structure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718961     DOI: 10.1016/0005-2744(78)90271-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

Authors:  R F Schinazi; R T Scott; J Peters; V Rice; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

Review 2.  Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

Authors:  N S Brown; R Bicknell
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

Review 3.  Thymidine phosphorylase: A potential new target for treating cardiovascular disease.

Authors:  Wei Li; Hong Yue
Journal:  Trends Cardiovasc Med       Date:  2017-10-20       Impact factor: 6.677

4.  Targeting Thymidine Phosphorylase With Tipiracil Hydrochloride Attenuates Thrombosis Without Increasing Risk of Bleeding in Mice.

Authors:  Adam Belcher; Abu Hasanat Md Zulfiker; Oliver Qiyue Li; Hong Yue; Anirban Sen Gupta; Wei Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-10       Impact factor: 8.311

5.  A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.

Authors:  G Ranieri; L Grammatica; R Patruno; A F Zito; P Valerio; S Iacobellis; C Gadaleta; G Gasparini; D Ribatti
Journal:  J Cell Mol Med       Date:  2007-03-22       Impact factor: 5.310

6.  Distinct substrate specificity and physicochemical characterization of native human hepatic thymidine phosphorylase.

Authors:  Taesung Oh; Mahmoud H El Kouni
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer.

Authors:  Nicola Zizzo; Giuseppe Passantino; Roberta Maria D'alessio; Antonella Tinelli; Giuseppe Lopresti; Rosa Patruno; Domenico Tricarico; Fatima Maqoud; Rosa Scala; Francesco Alfredo Zito; Girolamo Ranieri
Journal:  Front Vet Sci       Date:  2019-10-25

Review 8.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

Review 9.  The Platelet Response to Tissue Injury.

Authors:  Felix Eisinger; Johannes Patzelt; Harald F Langer
Journal:  Front Med (Lausanne)       Date:  2018-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.